هل أنت مستخدم جديد؟ قم بالتسجيل الآن
تسجيل الدخول
| إنشاء حساب
close
CEFAXONE IM/IV - 1g - 10
| التصنيف العلاجي | أساسي / جنيسي | التركيبة العلمية | الرمز | رقم التسجيل | الاسم | العيار | حجم العبوة | الشكل الصيدلاني | طريقة الاستعمال | الوكيل | مختبر | بلد التصنيع | سعر المبيع من العموم | هامش ربح الصيدلي | الشريحة | الجهة المسؤولة | البلد المسؤول | تاريخ المؤشر | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J01DD04 | G | Ceftriaxone - 1g | 11835 | 69724/1 | CEFAXONE IM/IV | 1g | 10 | Injectable lyophilised powder for solution | IV/IM | PMD (Pharmacist's medical drugstore) | Unimed Laboratories | Tunisia | 3,628,375 L.L | 23.08 | B | Unimed Laboratories | Tunisia | 12/12/20 | 0 |
أدوية ذات تركيبة مماثلة
| التصنيف العلاجي | أساسي / جنيسي | التركيبة العلمية | الرمز | رقم التسجيل | الاسم | العيار | حجم العبوة | الشكل الصيدلاني | طريقة الاستعمال | الوكيل | مختبر | بلد التصنيع | سعر المبيع من العموم | هامش ربح الصيدلي | الشريحة | الجهة المسؤولة | البلد المسؤول | تاريخ المؤشر | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J01DD04 | B | Ceftriaxone (sodium) - 1g | 1570 | 25468 | ROCEPHIN IV | 1g | 1 x 10ml | Injectable lyophilised powder for solution+diluent | Infusion/IV | Omnipharma | F. Hoffmann La Roche Ltd | Switzerland | 757,927 L.L | 23.08 | A2 | 12/12/20 | 0 | ||
| J01DD04 | B | Ceftriaxone (sodium) - 1g | 1571 | 25465 | ROCEPHIN IM | 1g | 1 x 3.5ml | Injectable lyophilised powder for solution+diluent | IM | Omnipharma | F. Hoffmann La Roche Ltd | Switzerland | 731,050 L.L | 23.08 | A2 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 755 | 208619/03 | AXONE | 1g | 10 | Injectable powder for solution | Infusion/IV | Picomed SARL | Pharma International Co | Jordan | 4,053,029 L.L | 23.08 | B | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 1617 | 236978/99 | TRIAXONE | 1g | 1 | Injectable powder for solution | IM | Pharmanet Drugstore S.A.R.L. | Julphar | United Arab Emirates | 438,093 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 2271 | 973948/02 | CEFTRIAXONE PANPHARMA | 1g | 25 | Injectable powder for solution | Infusion/IV/IM | Minapharm Halabi | Panpharma | France | 8,005,714 L.L | 21.26 | C | Panpharma | France | 12/12/20 | 0 |
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 2332 | 974033/02 | VERACOL | 1g | 1 x 10ml | Injectable lyophilised powder for solution+diluent | Infusion/IV | Macromed S.A.R.L. | Demo SA | Greece | 454,219 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 3263 | 208382/02 | TRAVILAN IM | 1g | 1 x 3.5ml | Injectable lyophilised powder for solution+diluent | IM | Medi drug International SAL (MDI) | Anfarm Hellas SA | Greece | 438,093 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (disodium) - 1g | 5201 | 194126/05 | MEDAXONUM | 1g | 1 | Injectable powder for solution+diluent | IM | New Allpharma | Medochemie Ltd | Cyprus | 438,093 L.L | 23.08 | A1 | Medochemie Ltd | Cyprus | 12/12/20 | 0 |
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 5716 | 219715/09 | TRIAXONE | 1g | 10 | Injectable powder for solution | IV/IM | Pharmanet Drugstore S.A.R.L. | Julphar | United Arab Emirates | 4,542,188 L.L | 23.08 | B | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (disodium) - 1g | 6912 | 96709/12 | MEDAXONUM | 1g | 50 | Injectable powder for solution | Infusion/IV/IM | New Allpharma | Medochemie Ltd | Cyprus | 15,482,229 L.L | 19.35 | D | Medochemie Ltd | Cyprus | 12/12/20 | 0 |
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 7779 | 87414/1 | MESPORIN-1000 IV | 1,000mg | 1 x 10ml | Injectable powder for solution+diluent | Infusion/IV | Mectapharm S.A.L. | Labesfal Laboratorios Almiro SA | Portugal | 417,935 L.L | 23.08 | A1 | Acino AG | Germany | 12/12/20 | 0 |
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 7923 | 106514/1 | MESPORIN-1000 IM | 1,000mg | 1 x 3.5ml | Injectable powder for solution+diluent | IM | Mectapharm S.A.L. | Labesfal Laboratorios Almiro SA | Portugal | 417,935 L.L | 23.08 | A1 | Acino AG | Germany | 12/12/20 | 0 |
| J01DD04 | G | Ceftriaxone - 1g | 9127 | 187458/13 | ROCICARE | 1g | 50 | Injectable powder for solution | IV/IM | Drugstore 3U S.A.R.L. | Swiss Exports PVT - Ltd | India | 9,382,061 L.L | 21.26 | C | Swiss Exports PVT - Ltd | India | 12/12/20 | 0 |
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 9696 | 67018/1 | AXONE 1G IM | 1g | 1+1 | Injectable powder for solution+diluent | IM | Picomed SARL | Pharma International Co | Jordan | 438,093 L.L | 23.08 | A1 | Pharma International Co | Jordan | 12/12/20 | 0 |
| J01DD04 | G | Ceftriaxone - 1g | 11583 | 66822/1 | CEFAXONE | 1g | 1 | Injectable powder | IM | PMD (Pharmacist's medical drugstore) | Unimed Laboratories | Tunisia | 403,153 L.L | 23.08 | A1 | Unimed Laboratories | Tunisia | 12/12/20 | 0 |
| J01DD04 | G | Ceftriaxone - 1g | 11836 | 69524/1 | CEFAXONE IV | 1g | 1 | Injectable lyophilised powder for solution+diluent | IV/IM | PMD (Pharmacist's medical drugstore) | Unimed Laboratories | Tunisia | 403,153 L.L | 23.08 | A1 | Unimed Laboratories | Tunisia | 12/12/20 | 0 |
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 6784 | 97385/12 | LEBACEF | 1g | 1 x 10ml | Injectable powder for solution+diluent | IV | Raymond Georges Abou Adal & Co | Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 643,765 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g, Lidocaine (ampoule) - | 6785 | 97384/12 | LEBACEF | 1g | 1 x 3.5ml | Injectable powder for solution+diluent | IM | Raymond Georges Abou Adal & Co | Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 568,253 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 6892 | 97493/12 | LEBACEF | 1g | 10 | Injectable powder for solution | IV/IM | Raymond Georges Abou Adal & Co | Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 5,793,881 L.L | 23.08 | B | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 7617 | 45614/1 | LEBACEF | 1g | 1 x 10ml | Injectable powder for solution+diluent | IV | Raymond Georges Abou Adal & Co | Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 508,100 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone - 1g/3.5ml, Lidocaine (ampoule) - | 7818 | 69714/1 | MEGION-A | 1g/3.5ml | 1 x 3.5ml | Injectable powder + solvent | IM | Khalil Fattal & Fils S.A.L. | Pharmaline under license from Sandoz GmbH, Austria | Lebanon | 567,731 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (disodium 3.5 hydrate) - 1g | 9144 | 161716/1 | MEGION | 1g | 1 x 10ml | Injectable powder for solution+diluent | Infusion/IV/IM | Khalil Fattal & Fils S.A.L. | Pharmaline Licensed by Sandoz GmbH, KUNDL, Austria | Lebanon | 522,803 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone - 1g | 10075 | 152519/1 | LEBACEF | 1g | 1+1 | Injectable sterile powder for solution + lidocaine solvent | IM | Raymond Georges Abou Adal & Co | Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 508,100 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone - 1g | 10928 | 50622/1 | LEBACEF | 1g | 1+1 | Injectable sterile powder for solution + lidocaine solvent | IM | Raymond Georges Abou Adal & Co | ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 508,100 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 10929 | 50422/1 | LEBACEF | 1g | 1 | Injectable powder for solution+diluent | IV | Raymond Georges Abou Adal & Co | ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 508,100 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 10930 | 50222/1 | LEBACEF | 1g | 10 | Injectable powder for solution | IV/IM | Raymond Georges Abou Adal & Co | ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 5,793,881 L.L | 23.08 | B | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 10931 | 50522/1 | LEBACEF | 1g | 1 x 10ml | Injectable powder for solution+diluent | IV | Raymond Georges Abou Adal & Co | ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 643,765 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g, Lidocaine (ampoule) - | 10932 | 50322/1 | LEBACEF | 1g | 1 x 3.5ml | Injectable powder for solution+diluent | IM | Raymond Georges Abou Adal & Co | ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 568,253 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
| J01DD04 | G | Ceftriaxone (sodium) - 1g | 11720 | FE9924/1 | LEBACEF | 1g | 10 | Injectable powder for solution | IV/IM | Raymond Georges Abou Adal & Co | ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 5,793,881 L.L | 23.08 | B | 12/12/20 | 0 |
Sitemap
حقوق الطبع والنشر محفوظة ل وزارة الصحة العامة ©2024